89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
8.11
+0.41 (5.32%)
At close: May 12, 2025, 4:00 PM
7.99
-0.12 (-1.48%)
After-hours: May 12, 2025, 5:38 PM EDT
89bio Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for 89bio stock have an average target of 27.25, with a low estimate of 11 and a high estimate of 49. The average target predicts an increase of 236.00% from the current stock price of 8.11.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 14, 2025.
Analyst Ratings
The average analyst rating for 89bio stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 5 | 5 | 4 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 9 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Initiates $11 | Hold | Initiates | $11 | +35.64% | Mar 14, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +208.26% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $29 → $21 | Strong Buy | Reiterates | $29 → $21 | +158.94% | Feb 28, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 4, 2025 |
| UBS | UBS | Strong Buy Maintains $25 → $38 | Strong Buy | Maintains | $25 → $38 | +368.56% | Jan 31, 2025 |
Financial Forecast
Revenue This Year
n/a
from 847.98M
Revenue Next Year
n/a
EPS This Year
-2.08
from -3.51
EPS Next Year
-2.11
from -2.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 26.3M | 98.7M | ||
| Avg | n/a | 6.6M | 38.0M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 1,398.6% | ||
| Avg | - | - | 477.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.67 | -1.43 | -1.49 | ||
| Avg | -2.08 | -2.11 | -1.94 | ||
| Low | -2.40 | -2.45 | -2.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.